The Immunology Market Size was valued at USD 97.58 Billion in 2023
Ketanthorat11 Apr, 2025Health
The rising demand for biosimilars due to their similar efficacy and cheaper alternatives is significantly propelling the adoption of biosimilars in developed and developing regions. The higher cost of biologics hinders the availability and affordability of drugs for the patient population in developing regions. For example, Neulasta, a drug developed by Amgen to fight off infections for chemotherapy patients, costs over USD 10,000 per ml; whereas, its biosimilar, Ziexentzo, costs around USD 6500 per ml.
Related Bookmarks
- Stop Dental Decay with Dental Fillings in Allen Texas
- The Integrated Approach: How London’s Breast Surgeons Collaborate for Better Care
- The Integrated Approach: How London’s Breast Surgeons Collaborate for Better Care
- Orthodontic Experts Aurora Near Naperville
- The Integrated Approach: How London’s Breast Surgeons Collaborate for Better Care
- RA and JIA: Spot The Signs, Protect Your Joints
- What Advanced Technologies Are Used by the Best SICU Hospitals in Etawah?
- Book an Appointment with a Hyde Park Eye Doctor – Conveniently Located Near
- Holistic Approaches to Breast Surgery in London: Beyond the Operating Room
- Need the Best Skin Doctor Near Me to Cure All Skin Issues
Recent Profiles
Gustav Ulm
U888
789win
88aa
Thay Pin Iphone Tại Nhà
Swd Decor
Chatgpt Gratis Cl
Herman Kronborg
Hayden Reddy
Nirvana Singapore